HIGHLIGHTS
- who: Expression Profiles and colleagues from the Fudan University, China have published the article: Comprehensive Analysis of VCAN Expression Pro les and Prognostic Values in HCC, in the Journal: (JOURNAL)
- what: The research shows that low expression of VCAN can significantly improve the survival time of HCC patients, which implied that VCAN may be the downstream or upstream target of CSF1R in HCC, and is partly involved in its cancer-promoting effect. The study provides a new anti-hepatoma idea to find some DNA methyltransferase inhibitors and TF inhibitors that can effectively down-regulate the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.